Journal
Nature Communications
Publication Date
5-9-2022
Volume
13
Issue
1
First Page
2526
Document Type
Open Access Publication
DOI
10.1038/s41467-022-30142-9
Rights and Permissions
Pereira, P.M.R., Mandleywala, K., Monette, S. et al. Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nat Commun 13, 2526 (2022). doi.org/10.1038/s41467-022-30142-9 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Pereira, Patrícia M R; Mandleywala, Komal; Monette, Sébastien; Lumish, Melissa; Tully, Kathryn M; Panikar, Sandeep Surendra; Cornejo, Mike; Mauguen, Audrey; Ragupathi, Ashwin; Keltee, Nai C; Mattar, Marissa; Janjigian, Yelena Y; and Lewis, Jason S, "Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer." Nature Communications. 13, 1. 2526 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11907
Supplementary Information
41467_2022_30142_MOESM2_ESM.pdf (3554 kB)
Reporting Summary
41467_2022_30142_MOESM3_ESM.pdf (3409 kB)
Peer Review File
